Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Computational Biology

Background:

• The tumor-homing peptide CREKA targets fibrin and associated proteins in tumor vasculature.
• Improving CREKA's stability and tumor-homing ability can enhance its therapeutic potential.

Purpose of the Study:

• To engineer CREKA analogs with improved tumor growth inhibition.
• To stabilize the bioactive conformation of CREKA using computational modeling and chemical modifications.

Main Methods:

• Computer modeling (simulated annealing, molecular dynamics) to design CREKA analogs.
• Incorporation of non-proteinogenic amino acids (α-methyl and N-methyl derivatives) into CREKA.
• Synthesis and biological assays to evaluate analog efficacy and tumor accumulation.

Main Results:

• Computational modeling predicted stabilization of the CREKA bioactive conformation.
• Engineered CREKA analogs demonstrated increased tumor accumulation correlating with conformational stability.
• The modified CREKA analogs showed improved ability to inhibit tumor growth.

Conclusions:

• Chemical engineering strategies can enhance the tumor-homing and inhibitory properties of CREKA.
• Computational modeling is a valuable tool for rational drug design and optimization.
• Multidisciplinary collaboration can lead to significant biomedical advancements.